Header Logo

Connection

Yasu Morita to Feasibility Studies

Back to Details
This is a "connection" page, showing publications Yasu Morita has written about Feasibility Studies.
Yasu Morita
Connection Strength
0.126
Feasibility Studies
  1. Morita Y, Maeda Y, Yamaguchi T, Urase F, Kawata S, Hanamoto H, Tsubaki K, Ishikawa J, Shibayama H, Matsumura I, Matsuda M. Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial. Cancer Sci. 2018 Oct; 109(10):3209-3215.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.